GlassScriptPhysician profile
Sean Sussman
NPI 1316468895
$1,708.65
in general payments reported to CMS, 2019-2025
16 companies · $680 in 2025
The $680 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $107 · 2023: $340 · 2024: $581 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.37 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $571.98 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $348.09 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $201.63 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $152.97 | 2022-2025 | |
| Abbvie INC. | $107.93 | 2023-2025 | Qulipta, Ubrelvy, Vraylar |
| Glaxosmithkline, LLC. | $95.03 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Astellas Pharma US INC | $38.51 | 2022-2023 | Myrbetriq, Veozah |
| Abbott Laboratories | $34.58 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $27.41 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $23.32 | 2023 | Aptima |
| Inspire Medical Systems, INC. | $20.42 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $19.52 | 2025 | |
| Axsome Therapeutics, INC. | $18.57 | 2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $18.07 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $15.93 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $14.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Sussman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.